What is Mounjaro
Mounjaro is a medicine with the active ingredient tirzepatide. It is used for two medical applications:
- Weight loss and weight management in adults with obesity (BMI ≥ 30) or overweight (BMI 27–30) with weight-related health problems, such as high blood pressure, sleep apnea, or high cholesterol.
- Treatment of type 2 diabetes in adults when diet and exercise alone are not sufficient to lower blood sugar.
Within The Body Clinic, a doctor assesses during the consultation whether treatment with medication is suitable within a medical weight management program. More information about our medical approach can be found in our treatment program.
Dosage Build-up
Treatment with Mounjaro starts with a low dose of 2.5 mg per week. The dosage can then be gradually increased, depending on the effect and how well you tolerate the medication. There must be at least four weeks between two dose increases. If the dosage is increased every four weeks, the build-up is as follows:
| Month | Dosage once per week |
|---|---|
| Month 1 | 2.5 mg |
| Month 2 | 5 mg |
| Month 3 | 7.5 mg |
| Month 4 | 10 mg |
| Month 5 | 12.5 mg |
| Month 6 | 15 mg |
Instructions for using Mounjaro
Below you will find brief usage information for the pen. Always read the package leaflet or ask your doctor/pharmacist for explanations.
Important information about the pen
- Each pen contains one fixed dosage.
- You can inject 4 times with one pen (once a week).
- After 4 injections, the pen automatically locks.
- Some residual fluid always remains; this is not a full dose.
Check before each injection
- Attach a new needle to the pen.
- Turn the back 2 clicks until the first line appears in the window.
- Press the back until a '0' reappears on the screen.
- If a drop appears at the needle, the pen is ready for use.
- If you don't see a drop, repeat the steps; if this persists after 2 attempts, replace the needle and repeat the check.
- If a drop appears, fully turn the pen until '1' appears on the screen and administer the dose.
Storage
- In the refrigerator (2–8 °C), do not freeze and protect from light.
- After opening: up to 30 days at room temperature (max. 30 °C) possible.
Tirzepatide
Tirzepatide is the active ingredient in Mounjaro and is produced by Eli Lilly. It is an incretin mimetic: a substance that mimics the action of incretins, hormones that your intestines produce as soon as you eat. Tirzepatide activates both the GIP and GLP-1 receptors. These receptors play a role in the release of insulin after a meal, the reduction of glucagon secretion, and the influencing of appetite and satiety. Through this combined action, tirzepatide helps regulate blood sugar and supports weight loss and weight management for the appropriate indications.
Tirzepatide works glucose-dependently: the pancreas only produces extra insulin if blood sugar rises. This means the risk of low blood sugar is small as long as you do not use other blood sugar-lowering medications. Because tirzepatide remains active in the body for a long time, one injection per week is sufficient.
Tirzepatide was the first medicine to act on two incretin receptors simultaneously. This is the main difference from other weight loss medications that only work via GLP-1:
- Semaglutide (Wegovy, Ozempic, Wegovy pill, Rybelsus): GLP-1 only, as a weekly injection or as a daily tablet taken on an empty stomach.
- Orforglipron (Foundayo: GLP-1 only, as a daily tablet that can be taken at any time. Not yet available in the Netherlands.
In a study directly comparing tirzepatide and semaglutide, participants on tirzepatide lost an average of about 20% of their body weight after 72 weeks, compared to about 14% with semaglutide. Results vary per person.
Tirzepatide was approved in Europe in 2022 for type 2 diabetes and later also for weight management. Its efficacy and safety have been investigated in the SURPASS studies (type 2 diabetes) and the SURMOUNT studies (obesity and overweight), involving thousands of adults. In the United States, the same substance for weight loss is sold as Zepbound. Read more about its action, research results, and side effects in our blog What is tirzepatide?














